Review



cfda se  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    MedChemExpress cfda se
    In vitro therapeutic effect of aCD47-CATE. (A) The cell viability of Hepa1-6 cells after different treatments (100 μg/mL), as determined by CCK-8 assay (n = 5). (B) Confocal laser scanning microscopy (CLSM) images of TUNEL staining (red) in Hepa1-6 cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. (C) Quantitative analysis of the TUNEL-positive cells from (B). Data are presented as mean ± SD (n = 3). (D) Flow cytometry analysis of apoptosis in Hepa1-6 cells after different treatments (n = 3). (E) Flow cytometric analysis of the M1 macrophage marker CD80 in RAW264.7 cells after co-culture with conditioned media from the treated Hepa1-6 cells. (F) CLSM images showing the infiltration of <t>CFDA-SE-labeled</t> M1 macrophages (green) into Hepa1-6 tumor spheroids. Scale bar = 200 μm. (G) Quantitative analysis of the fluorescence intensity of infiltrated macrophages in (F). Data are presented as mean ± SD (n = 3). ns P > 0.05; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001,∗∗∗∗p < 0.0001.
    Cfda Se, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 186 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA-SE/pmc13054091-348-7-8
    Average 97 stars, based on 186 article reviews
    cfda se - by Bioz Stars, 2026-11
    97/100 stars

    Images

    1) Product Images from "Macrophage exosome-engineered nanoplatform with pH-responsive ratiometric photoacoustic and NIR-II fluorescence imaging for guided photothermal immunotherapy of hepatocellular carcinoma"

    Article Title: Macrophage exosome-engineered nanoplatform with pH-responsive ratiometric photoacoustic and NIR-II fluorescence imaging for guided photothermal immunotherapy of hepatocellular carcinoma

    Journal: Materials Today Bio

    doi: 10.1016/j.mtbio.2026.103058

    In vitro therapeutic effect of aCD47-CATE. (A) The cell viability of Hepa1-6 cells after different treatments (100 μg/mL), as determined by CCK-8 assay (n = 5). (B) Confocal laser scanning microscopy (CLSM) images of TUNEL staining (red) in Hepa1-6 cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. (C) Quantitative analysis of the TUNEL-positive cells from (B). Data are presented as mean ± SD (n = 3). (D) Flow cytometry analysis of apoptosis in Hepa1-6 cells after different treatments (n = 3). (E) Flow cytometric analysis of the M1 macrophage marker CD80 in RAW264.7 cells after co-culture with conditioned media from the treated Hepa1-6 cells. (F) CLSM images showing the infiltration of CFDA-SE-labeled M1 macrophages (green) into Hepa1-6 tumor spheroids. Scale bar = 200 μm. (G) Quantitative analysis of the fluorescence intensity of infiltrated macrophages in (F). Data are presented as mean ± SD (n = 3). ns P > 0.05; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001,∗∗∗∗p < 0.0001.
    Figure Legend Snippet: In vitro therapeutic effect of aCD47-CATE. (A) The cell viability of Hepa1-6 cells after different treatments (100 μg/mL), as determined by CCK-8 assay (n = 5). (B) Confocal laser scanning microscopy (CLSM) images of TUNEL staining (red) in Hepa1-6 cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. (C) Quantitative analysis of the TUNEL-positive cells from (B). Data are presented as mean ± SD (n = 3). (D) Flow cytometry analysis of apoptosis in Hepa1-6 cells after different treatments (n = 3). (E) Flow cytometric analysis of the M1 macrophage marker CD80 in RAW264.7 cells after co-culture with conditioned media from the treated Hepa1-6 cells. (F) CLSM images showing the infiltration of CFDA-SE-labeled M1 macrophages (green) into Hepa1-6 tumor spheroids. Scale bar = 200 μm. (G) Quantitative analysis of the fluorescence intensity of infiltrated macrophages in (F). Data are presented as mean ± SD (n = 3). ns P > 0.05; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001,∗∗∗∗p < 0.0001.

    Techniques Used: In Vitro, CCK-8 Assay, Confocal Laser Scanning Microscopy, TUNEL Assay, Staining, Flow Cytometry, Marker, Co-Culture Assay, Labeling, Fluorescence

    Related Articles

    Double Staining:

    Article Title: Myeloid cell reprogramming combined with zoledronic acid effectively suppresses bone metastasis.
    Article Snippet: .. Cytotoxicity was assessed by co-culturing CD8+ T cells with tumor cells at an effector-to-target (E:T) ratio of 5:1, followed by CFSE/PI double staining (MedChemExpress, Monmouth Junction, NJ, USA) to evaluate cell viability, as previously described35. .. Cytotoxicity was assessed by co-culturing CD8+ T cells with tumor cells at an effector-to-target (E:T) ratio of 5:1, followed by CFSE/PI double staining (MedChemExpress, Monmouth Junction, NJ, USA) to evaluate cell viability, as previously described35.

    Single Cell:

    Article Title: LIM and SH3 protein 1 deficiency confers resistance to cytotoxic lymphocyte-mediated lysis and immunotherapy in gastric cancer by disrupting cytoskeleton dynamics
    Article Snippet: .. Briefly, a single-cell suspension of PKH26 (HY-D1451, MCE)-labeled tumor cells and CFDA-SE-labeled effector cells were mixed at an E:T ratio of 2:1 and incubated at 37°C for 30 min. .. The relative proportions of double-positive effector-target cell conjugations in each tube were determined by two-color flow cytometry using a FACSCanto II (BD Biosciences) and analyzed using FlowJo V.10.8 software.

    Suspension:

    Article Title: LIM and SH3 protein 1 deficiency confers resistance to cytotoxic lymphocyte-mediated lysis and immunotherapy in gastric cancer by disrupting cytoskeleton dynamics
    Article Snippet: .. Briefly, a single-cell suspension of PKH26 (HY-D1451, MCE)-labeled tumor cells and CFDA-SE-labeled effector cells were mixed at an E:T ratio of 2:1 and incubated at 37°C for 30 min. .. The relative proportions of double-positive effector-target cell conjugations in each tube were determined by two-color flow cytometry using a FACSCanto II (BD Biosciences) and analyzed using FlowJo V.10.8 software.

    Article Title: KYNU in Gastric Cancer Cells Promotes Tumor Progression by Influencing Macrophage Polarization Via PF4.
    Article Snippet: .. The cell suspension was then incubated with CFSE (MedChemExpress, China) under light- protected conditions at 37°C for 10 min. ..

    Incubation:

    Article Title: LIM and SH3 protein 1 deficiency confers resistance to cytotoxic lymphocyte-mediated lysis and immunotherapy in gastric cancer by disrupting cytoskeleton dynamics
    Article Snippet: .. Briefly, a single-cell suspension of PKH26 (HY-D1451, MCE)-labeled tumor cells and CFDA-SE-labeled effector cells were mixed at an E:T ratio of 2:1 and incubated at 37°C for 30 min. .. The relative proportions of double-positive effector-target cell conjugations in each tube were determined by two-color flow cytometry using a FACSCanto II (BD Biosciences) and analyzed using FlowJo V.10.8 software.

    Article Title: KYNU in Gastric Cancer Cells Promotes Tumor Progression by Influencing Macrophage Polarization Via PF4.
    Article Snippet: .. The cell suspension was then incubated with CFSE (MedChemExpress, China) under light- protected conditions at 37°C for 10 min. ..



    Similar Products

    93
    Dojindo Labs nih3t3 cells
    Nih3t3 Cells, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/Cellstain+CFSE/pm42868717-86-5-12
    Average 93 stars, based on 1 article reviews
    nih3t3 cells - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    95
    TargetMol carboxyfluorescein diacetate succinimidyl ester 122 cfse
    Carboxyfluorescein Diacetate Succinimidyl Ester 122 Cfse, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFSE/pm42988020-57-0-8
    Average 95 stars, based on 1 article reviews
    carboxyfluorescein diacetate succinimidyl ester 122 cfse - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    Beyotime cfda se dye
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Cfda Se Dye, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA+SE/pmc13755073-158-19-23
    Average 96 stars, based on 1 article reviews
    cfda se dye - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Beyotime cfdase
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Cfdase, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA+SE/pm42995598-54-0-6
    Average 96 stars, based on 1 article reviews
    cfdase - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Beyotime cfda se cfse
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Cfda Se Cfse, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA+SE/pm42886791-415-9-13
    Average 96 stars, based on 1 article reviews
    cfda se cfse - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    97
    MedChemExpress cfse stock solution
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Cfse Stock Solution, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA-SE/pm42869131-83-4-7
    Average 97 stars, based on 1 article reviews
    cfse stock solution - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    97
    MedChemExpress cfse
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Cfse, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA-SE/10__1002_slash_adfm__78518-285-0-6
    Average 97 stars, based on 1 article reviews
    cfse - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    96
    Beyotime wild type wt t gondii tachyzoites
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Wild Type Wt T Gondii Tachyzoites, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA+SE/pmc13689411-165-10-23
    Average 96 stars, based on 1 article reviews
    wild type wt t gondii tachyzoites - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with CFDA SE, and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.

    Journal: Alzheimer's & Dementia

    Article Title: Targeting peripheral cathepsin E restricts CD8 + T‐cell neuroinvasion and ameliorates Alzheimer's disease pathology

    doi: 10.1002/alz.71994

    Figure Lengend Snippet: CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with CFDA SE, and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.

    Article Snippet: T cells were isolated from the spleens of AD or CatE‐KO AD mice, activated in culture, and stained with CFDA SE dye (C1031, Beyotime) before being added to the 24‐well plate.

    Techniques: Migration, Pore Size, Labeling, Membrane, Staining, Imaging, Control, Analysis, Knock-Out